SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC

EIN: 113106037 501(c)(3) Diseases & Disorders

Brooklyn, NY

Total Revenue
$483,355
Total Expenses
$483,415
Total Assets
$66,890
Net Assets
$66,588
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1992
Legal Domicile
NY
Phone
3475338485
Tax Period
2024-01-01 to 2024-12-31

SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC, founded in 1992, is a small nonprofit in the Diseases & Disorders sector that reported $483K in total revenue in fiscal year 2024.

Mission

To improve the quality of life for individuals and families living with sickle cell disease, and other inherited blood disorders.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $483,355
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $483,355

Expense Breakdown

Grants Paid $0
Salaries & Benefits $291,070
Fundraising Expenses $0
Program Expenses $483,415
Other Expenses $192,345
TOTAL EXPENSES $483,415

Year-over-Year Comparison

2024 2023 Change
Revenue $483,355 $483,475 0.0%
Expenses $483,415 $296,095 +0.6%
Net Income $-60 $187,380 -1.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
2
Independent Members
2
Employees
N/A
Volunteers
3

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
0
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
TERESA DAVIS PRESIDENT 20.00
Officer
$0 $0 $0
VIVIAN OKWUAGWU SECRETARY 20.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $483,355 $483,415 $66,890 $-60
2023 $421,315 $484,025 $45,761 $-62,710
2023 $262,347 $249,880 $12,769 $12,467
2022 $301,033 $219,856 $127,418 $81,177
2021 $245,519 $203,218 $127,376 $42,301
2020 $226,614 $219,662 $124,572 $6,952
2019 $248,103 $209,404 $126,619 $38,699
2018 $188,534 $163,543 $157,216 $24,991
Explore More Nonprofits
Top 100 Nonprofits in New York Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare SICKLE CELL THALASSEMIA PATIENTS NEWORKS INC with other nonprofits in New York and across the country.